These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 6359172)

  • 21. Nonspecific enhancement of host defenses against infection: experimental evidence of a new order of efficacy and safety.
    Polk HC; Calhoun JH; Lowrey LD; Blanchard SP; Brewer RJ; Adams ST; Chedid L
    Surgery; 1981 Aug; 90(2):376-80. PubMed ID: 7020139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muramyl dipeptide stimulation of particle clearance in several animal species.
    Waters RV; Ferraresi RW
    J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
    [No Abstract]   [Full Text] [Related]  

  • 23. Isolation of tumoricidal macrophages from lung melanoma metastases of mice treated systemically with liposomes containing a lipophilic derivative of muramyl dipeptide.
    Key ME; Talmadge JE; Fogler WE; Bucana C; Fidler IJ
    J Natl Cancer Inst; 1982 Nov; 69(5):1198-98. PubMed ID: 6957661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Inhibition of IgE antibody formation by tubercle bacilli and muramyl peptide].
    Kishimoto T
    Kekkaku; 1980 Oct; 55(10):467-70. PubMed ID: 6785511
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of tumoricidal properties in murine macrophages by intravenous injection of muramyl dipeptide encapsulated within liposomes as a treatment for spontaneous metastasis.
    Fidler IJ; Poste G
    Prog Clin Biol Res; 1981; 75B():257-67. PubMed ID: 7323097
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent advances concerning the use of muramyl dipeptide derivatives as vaccine potentiators.
    Audibert F; Chedid L
    Prog Clin Biol Res; 1980; 47():325-38. PubMed ID: 7010376
    [No Abstract]   [Full Text] [Related]  

  • 27. Microbial agents in cancer treatment.
    Clark JW
    Curr Probl Dermatol; 1989; 18():277-82. PubMed ID: 2663370
    [No Abstract]   [Full Text] [Related]  

  • 28. Possible treatment of AIDS patients with live lactobacteria.
    Tihole F
    Med Hypotheses; 1988 May; 26(1):85-8. PubMed ID: 3135468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotoxicity of immunotherapeutic agents.
    Johnson AG; Regal J
    Springer Semin Immunopathol; 1985; 8(4):347-59. PubMed ID: 2418519
    [No Abstract]   [Full Text] [Related]  

  • 30. Cancer immunity: fact or fiction?
    Moore GE
    Tex Med; 1968 Oct; 64(10):54-9. PubMed ID: 5682786
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunity in neoplasms].
    Hammer D
    Zentralbl Veterinarmed B; 1968 Feb; 15(1):51-5. PubMed ID: 5685442
    [No Abstract]   [Full Text] [Related]  

  • 32. Biologic therapy of cancer.
    Scott OC
    Br J Cancer; 1996 May; 73(10):1312. PubMed ID: 8630298
    [No Abstract]   [Full Text] [Related]  

  • 33. Experiments in immunity in cancer.
    MURRAY G
    Can Med Assoc J; 1958 Aug; 79(4):249-59. PubMed ID: 13573269
    [No Abstract]   [Full Text] [Related]  

  • 34. The generation of tumoricidal activity in macrophages for the treatment of established metastases.
    Fidler IJ
    Symp Fundam Cancer Res; 1983; 36():421-35. PubMed ID: 6382518
    [No Abstract]   [Full Text] [Related]  

  • 35. Potential therapeutic value of muramyl peptides for modulating human immunologic responses.
    Fogler WE
    Biotechnol Ther; 1989-1990; 1(1):69-83. PubMed ID: 2562645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines.
    Chedid L; Audibert F; Jolivet M; Carelli C; Uzan M; Gras-Masse H; Tarter A
    Ann Sclavo Collana Monogr; 1984; 1(2):77-85. PubMed ID: 6400358
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential use of muramyl peptides in cancer therapy.
    Chedid LA
    Prog Clin Biol Res; 1983; 132E():261-71. PubMed ID: 6359172
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.